At close: 3:29:58 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
14,459,800.00
13,663,000.00
14,182,750.00
14,101,720.00
13,520,350.00
Cost of Revenue
8,381,150.00
8,131,150.00
8,985,120.00
8,444,360.00
7,365,620.00
Gross Profit
6,078,650.00
5,531,850.00
5,197,630.00
5,657,360.00
6,154,730.00
Operating Expense
5,073,740.00
5,161,640.00
5,194,780.00
4,983,410.00
4,402,510.00
Operating Income
1,004,910.00
370,210.00
2,850.00
673,950.00
1,752,220.00
Net Non Operating Interest Income Expense
-550,260.00
-474,160.00
-343,080.00
-155,330.00
-237,570.00
Pretax Income
240,240.00
-546,460.00
-1,376,580.00
529,300.00
1,366,290.00
Tax Provision
-33,230.00
-250,330.00
-156,810.00
81,660.00
321,770.00
Net Income Common Stockholders
164,810.00
-358,690.00
-1,211,590.00
409,550.00
954,420.00
Diluted NI Available to Com Stockholders
164,810.00
-358,690.00
-1,211,590.00
409,550.00
954,420.00
Basic EPS
0.67
-1.44
-4.88
1.65
3.87
Diluted EPS
0.66
-1.44
-4.88
1.63
3.85
Basic Average Shares
247,643.63
248,624.52
248,471.25
247,408.75
246,879.75
Diluted Average Shares
252,325.34
249,882.81
250,114.40
250,733.25
247,870.49
Rent Expense Supplemental
--
42,460.00
34,040.00
19,940.00
10,410.00
Total Expenses
13,454,890.00
13,292,790.00
14,179,900.00
13,427,770.00
11,768,130.00
Net Income from Continuing & Discontinued Operation
164,810.00
-358,690.00
-1,211,590.00
409,550.00
954,420.00
Normalized Income
177,340.00
-219,719.00
-300,028.90
411,469.74
1,019,677.72
Interest Income
--
6,700.00
12,090.00
2,410.00
6,260.00
Interest Expense
540,330.00
464,230.00
297,190.00
135,090.00
192,540.00
Net Interest Income
-550,260.00
-474,160.00
-343,080.00
-155,330.00
-237,570.00
EBIT
780,570.00
-82,230.00
-1,079,390.00
664,390.00
1,558,830.00
EBITDA
1,433,470.00
533,170.00
-522,460.00
1,179,800.00
2,064,810.00
Reconciled Cost of Revenue
8,381,150.00
8,131,150.00
8,985,120.00
8,444,360.00
7,365,620.00
Reconciled Depreciation
652,900.00
615,400.00
556,930.00
515,410.00
505,980.00
Net Income from Continuing Operation Net Minority Interest
164,810.00
-358,690.00
-1,211,590.00
409,550.00
954,420.00
Total Unusual Items Excluding Goodwill
-17,900.00
-198,530.00
-798,410.00
-2,270.00
-85,360.00
Total Unusual Items
-17,900.00
-198,530.00
-594,320.00
-2,270.00
-85,360.00
Normalized EBITDA
1,451,370.00
731,700.00
71,860.00
1,182,070.00
2,150,170.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-5,370.00
-59,559.00
-90,938.90
-350.26
-20,102.28
3/31/2021 - 3/10/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HIKAL.NS Hikal Limited
415.10
-3.16%
INDOCO.NS Indoco Remedies Limited
335.15
-1.90%
SUVENPHAR.NS Suven Pharmaceuticals Limited
1,276.35
-1.57%
GRANULES.NS Granules India Limited
589.30
+0.68%
AKUMS.NS AKUMS DRUGS AND PHARMA L
587.05
-4.20%
BAJAJHCARE.NS Bajaj HealthCare Limited
435.65
-1.18%
KILITCH.NS Kilitch Drugs (India) Limited
323.20
-1.67%
HESTERBIO.NS Hester Biosciences Limited
2,388.85
-1.74%
FDC.BO FDC Limited
510.15
-1.90%
BROOKS.NS Brooks Laboratories Limited
147.90
+2.00%